-
ATS 2026 Orlando Sessions Examine Recent Insights and Unique Challenges for Treating COPD
on
Recent reports show that chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States in 2023, with 141,733 deaths related to the disease during that year. Additionally, treatments for the disease incur annual medical costs of approximately $24 billion for adults aged 45 and older. Spyridon Fortis, MD, PhD, MSc, spoke with ATS Conference News about the current landscape of COPD therapies, previewing topics that will be explored throughout ATS 2026 Orlando programming.
More #ATS2026 News
-
Women’s Forum Panel Highlights Real-World Strategies for Career and Professional Growth
on
The Women’s Forum at the ATS 2026 International Conference is introducing a new twist: For the first time, the Forum will feature a talk-show format with five distinguished panelists. The discussion will focus on numerous crucial topics, offering practical perspectives to spur personal and professional growth. The event will be held from 11:45 a.m. –…
-
ATS Research Program Benefit Offers a Good Time for a Great Cause
on
For over 20 years, the ATS Research Program has supported early career investigators during their transition to independent research careers. ATS 2026 Orlando participants can help fund this critical program, meet grantees, and network by attending the ATS Research Program Benefit on Saturday, May 16, from 6 – 7:30 p.m. at the Hyatt Regency Orlando…